blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1263788

EP1263788 - IDENTIFICATION OF A DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.08.2014
Database last updated on 11.05.2024
Most recent event   Tooltip08.08.2014Application deemed to be withdrawnpublished on 10.09.2014  [2014/37]
Applicant(s)For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
The National Institute of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325
Rockville, MD 20852 / US
[N/P]
Former [2002/50]For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
c/o National Institutes of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325
Rockville, MD 20852-3804 / US
Inventor(s)01 / LENARDO, Michael J.
9117 Falls Chapel Way
Bethesda, MD 20854 / US
02 / CHAN, Francis Ka-Ming
14209 Parker Farm Way
Silver Spring, MD 20906 / US
03 / SIEGEL, Richard M.
5610 Roosevelt Street
Bethesda, Maryland 20817 / US
 [2013/48]
Former [2003/13]01 / LENARDO, Michael, J.
9117 Falls Chapel Way
Bethesda, MD 20854 / US
02 / CHAN, Francis, Ka-Ming
14209 Parker Farm Way
Silver Spring, MD 20906 / US
03 / SIEGEL, Richard, M.
5610 Roosevelt Street
Bethesda, Maryland 20817 / US
Former [2002/50]01 / LENARDO, Michael, J.
9117 Falls Chapel Way
Bethesda, MD 20854 / US
02 / CHAN, Francis, Ka-Ming
14209 Parker Farm Way
Silver Spring, MD 20906 / US
03 / SIEGEL, Richard, M.
Apt. 3, 2030 Hillyer Place, N.W.
Washington, DC 20009 / US
Representative(s)Leißler-Gerstl, Gabriele, et al
Hoefer & Partner
Patentanwälte mbB
Pilgersheimer Strasse 20
81543 München / DE
[N/P]
Former [2007/30]Leissler-Gerstl, Gabriele, et al
Hoefer & Partner Patentanwälte Pilgersheimer Strasse 20
81543 München / DE
Former [2007/19]Leissler-Gerstl, Gabriele, et al
European Patent Attorney Pilgersheimer Strasse 20
81543 München / DE
Former [2002/50]Leissler-Gerstl, Gabriele
Eisenführ, Speiser & Partner, Patentanwälte, Arnulfstrasse 25
80335 München / DE
Application number, filing date01910476.909.02.2001
[2002/50]
WO2001US04125
Priority number, dateUS20000181909P11.02.2000         Original published format: US 181909 P
[2002/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0158953
Date:16.08.2001
Language:EN
[2001/33]
Type: A2 Application without search report 
No.:EP1263788
Date:11.12.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 16.08.2001 takes the place of the publication of the European patent application.
[2002/50]
Search report(s)International search report - published on:EP21.02.2002
ClassificationIPC:C07K14/715, C12N15/12, C07K16/28
[2002/50]
CPC:
C07K14/7151 (EP,US); C07K16/28 (US); C07K16/2878 (US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/50]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:IDENTIFIZIERUNG EINER DOMÄNE IN DER FAMILIE DER TUMORNEKROSE-FAKTOR REZEPTOREN, DIE DIE ANORDNUNG DES REZEPTORS VOR DER LIGANDENBINDUNG UND SEINE FUNKTION VERMITTELT[2013/47]
English:IDENTIFICATION OF A DOMAIN IN THE TUMOR NECROSIS FACTOR RECEPTOR FAMILY THAT MEDIATES PRE-LIGAND RECEPTOR ASSEMBLY AND FUNCTION[2002/50]
French:IDENTIFICATION D'UN NOUVEAU DOMAINE DANS LA FAMILLE DES RECEPTEURS DU FACTEUR DE NECROSE TUMORALE MEDIANT L'ASSEMBLAGE ET LA FONCTION DU RECEPTEUR DE PRE-LIGAND[2002/50]
Former [2002/50]IDENTIFIZIERUNG EINER DOMÄNE IN DER FAMILIE DER TUMORNEKROSE-FAKTOR REZEPTOREN, DIE DIE ANORDNUNG DES REZEPTORS VOR DER LIGANDBINDUNG UND SEIN FUNKTION VERMITTELT
Entry into regional phase11.09.2002National basic fee paid 
21.08.2002Designation fee(s) paid 
21.08.2002Examination fee paid 
Examination procedure24.07.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
21.08.2002Examination requested  [2002/50]
13.01.2004Despatch of a communication from the examining division (Time limit: M06)
23.07.2004Reply to a communication from the examining division
21.09.2004Despatch of a communication from the examining division (Time limit: M06)
24.03.2005Reply to a communication from the examining division
22.02.2006Date of oral proceedings
24.03.2006Despatch of a communication from the examining division (Time limit: M02)
24.03.2006Minutes of oral proceedings despatched
22.05.2006Reply to a communication from the examining division
12.07.2006Despatch of communication that the application is refused, reason: substantive examination {1}
09.10.2009Despatch of a communication from the examining division (Time limit: M06)
19.04.2010Reply to a communication from the examining division
05.07.2010Despatch of a communication from the examining division (Time limit: M04)
15.11.2010Reply to a communication from the examining division
29.11.2010Despatch of a communication from the examining division (Time limit: M06)
31.05.2011Reply to a communication from the examining division
04.07.2011Despatch of a communication from the examining division (Time limit: M06)
13.01.2012Reply to a communication from the examining division
09.05.2012Despatch of a communication from the examining division (Time limit: M06)
12.11.2012Reply to a communication from the examining division
23.11.2012Despatch of a communication from the examining division (Time limit: M04)
20.03.2013Reply to a communication from the examining division
05.11.2013Communication of intention to grant the patent
18.03.2014Application deemed to be withdrawn, date of legal effect  [2014/37]
24.04.2014Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2014/37]
Appeal following examination13.09.2006Appeal received No.  T1815/06
21.11.2006Statement of grounds filed
01.07.2009Result of appeal procedure: continuation of examination procedure
01.07.2009Date of oral proceedings
14.07.2009Minutes of oral proceedings despatched
01.07.2009Date of oral proceedings
Divisional application(s)EP09008549.9   Application deemed to be withdrawn  : 31.07.2009
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.01.2004
Fees paidRenewal fee
25.02.2003Renewal fee patent year 03
23.02.2004Renewal fee patent year 04
22.02.2005Renewal fee patent year 05
27.02.2006Renewal fee patent year 06
27.02.2007Renewal fee patent year 07
25.02.2008Renewal fee patent year 08
26.02.2009Renewal fee patent year 09
24.02.2010Renewal fee patent year 10
23.02.2011Renewal fee patent year 11
24.02.2012Renewal fee patent year 12
27.02.2013Renewal fee patent year 13
Penalty fee
Additional fee for renewal fee
28.02.201414   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US5633145  (FELDMANN MARC [GB], et al) [X] 1-7,17-20,23,25-27 * column 5, lines 14-56 * * SEQ ID NO:26,27,29 *;
 [X]WO9801555  (AMGEN INC [US], et al) [X] 1,2,4-7,18-20,23,25 * page 45, lines 18-29 * * page 67, line 9 - page 68, line 16 * * figure 4 *;
 [X]WO9620206  (UAB RESEARCH FOUNDATION [US]) [X] 1,2,8,9,17-20,24,27 * examples I,,IX *;
 [X]JPH07289266  ;
 [A]WO9938525  (BIOGEN INC [US], et al) [A] 1,2,10,18-20,23,27 * page 5, line 30 - page 6, line 2 * * example 1 *;
 [A]US5866372  (STEIN HARALD [DE], et al) [A] 1,2,12,18-20,27 * column 3, lines 13-56 * * SEQ ID NO:2 *;
 [A]US5830731  (SEED BRIAN [US], et al) [A] 1,2,13,18-20,27 * example XIII * * column 66, lines 65-68 *;
 [A]WO9818824  (HUMAN GENOME SCIENCES INC [US], et al) [A] 1,2,14,18-20,23,25-27 * page 12, lines 6-15 * * page 30, lines 11-18 * * page 46, lines 13-21 * * page 52, lines 6-13 *;
 [A]WO9521915  (UNIV LELAND STANFORD JUNIOR [US], et al) [A] 1,2,15,18-20,23,25-27 * page 7, lines 22-24 * * page 75, line 12 - page 77, line 3 *;
 [A]WO9911791  (UNIV WASHINGTON [US]) [A] 1,2,16,18-20,23,27 * page 14, lines 15-21 * * figure 3 *;
 [X]  - PAPOFF GIULIANA ET AL, "Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor.", JOURNAL OF BIOLOGICAL CHEMISTRY., (19991231), vol. 274, no. 53, ISSN 0021-9258, pages 38241 - 38250, XP002174458 [X] 1-4,8,9,17-20,27 * page 38244, column R, paragraph L - page 38247, column R, paragraph 2; figures 4,8 *

DOI:   http://dx.doi.org/10.1074/jbc.274.53.38241
 [X]  - PINCKARD J KEITH ET AL, "Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells.", JOURNAL OF BIOLOGICAL CHEMISTRY, (1997), vol. 272, no. 16, ISSN 0021-9258, pages 10784 - 10789, XP002174459 [X] 4 * page 10787, column R, paragraph 2 - page 10788, paragraph 2; figure 5 *

DOI:   http://dx.doi.org/10.1074/jbc.272.16.10784
 [X]  - PAPOFF GIULIANA ET AL, "An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.", JOURNAL OF IMMUNOLOGY, (1996), vol. 156, no. 12, ISSN 0022-1767, pages 4622 - 4630, XP001015689 [X] 1-4,8,9,18-20,24,27,28 * page 4622, column R, paragraph L - page 4623, column L, paragraph 1 * * figure 5 *
 [X]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 1996, no. 02, Database accession no. 1996-015271, XP002174462 & JPH07289266 A 19951107 (MOCHIDA PHARM CO LTD) [X] 1,2,8,9,18-20,24,27 * abstract * * see sequence on page 522 *
 [A]  - POLLOK B A ET AL, "USING GFP IN FRET-BASED APPLICATIONS", TRENDS IN CELL BIOLOGY, ELSEVIER SCIENCE LTD, (199902), vol. 9, ISSN 0962-8924, pages 57 - 60, XP000949956 [A] 29,30 * page 59, column L - page 60, column L *

DOI:   http://dx.doi.org/10.1016/S0962-8924(98)01434-2
 [PX]  - CHAN FRANCIS KA-MING ET AL, "A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.", SCIENCE (WASHINGTON D C), (2000), vol. 288, no. 5475, ISSN 0036-8075, pages 2351 - 2354, XP002174460 [PX] 1-7,17-20,29,30 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.288.5475.2351
 [PX]  - SIEGEL RICHARD M ET AL, "Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.", SCIENCE (WASHINGTON D C), (2000), vol. 288, no. 5475, ISSN 0036-8075, pages 2354 - 2357, XP002174461 [PX] 1-5,8,9,17-20,29,30 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.288.5475.2354
Examination   - NCBI, (19950117), Database accession no. M75866, URL: NCBI
    - NCBI, (19950107), Database accession no. M32315, URL: NCBI
    - FUCHS ET AL., "Structure of the human TNF receptor 1 (p60) gene (TNRF1) and localization to chromosome 12p13.", GENOMICS, (1992), vol. 13, doi:doi:10.1016/0888-7543(92)90226-I, pages 219 - 224, XP024865250

DOI:   http://dx.doi.org/10.1016/0888-7543(92)90226-I
    - SMITH ET AL., "A receptor for tumor necrosi factor defines an unusual family of cellular and viral protein.", SCIENCE, (19900525), vol. 248, no. 4958, pages 1019 - 1023
by applicantUS5633145
 WO9801555
    - PAPOFF ET AL., "Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor", J BIOL CHEM., (19991231), vol. 274, no. 53, doi:doi:10.1074/jbc.274.53.38241, pages 38241 - 50, XP002174458

DOI:   http://dx.doi.org/10.1074/jbc.274.53.38241
    - FUCHS ET AL., "Structure of the human TNF receptor 1 (p60) gene (TNFR1) and localization to chromosome 12p13", GENOMICS, (1992), vol. 13, no. 1, doi:doi:10.1016/0888-7543(92)90226-I, pages 219 - 224, XP024865250

DOI:   http://dx.doi.org/10.1016/0888-7543(92)90226-I
    - SMITH ET AL., "A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins", SCIENCE, (1990), vol. 248, no. 4958, doi:doi:10.1126/science.2160731, pages 1019 - 1023, XP002107350

DOI:   http://dx.doi.org/10.1126/science.2160731
    - CHAN ET AL., "A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling", SCIENCE, (20000630), vol. 288, no. 5475, doi:doi:10.1126/science.288.5475.2351, pages 2351 - 4, XP002397593

DOI:   http://dx.doi.org/10.1126/science.288.5475.2351
    - POLLOCK ET AL., "Using GFP in FRET-based applications", TRENDS CELL BIOL., (199902), vol. 9, no. 2, pages 57 - 60
    - K. J. TRACEY; A. CERAMI, ANNU. REV. CELL BIO., (1993), vol. 9, page 317
    - K. J. TRACEY; A. CERAMI, ANNU. REV. MED., (1994), vol. 45, page 491
    - H. WAJANT; K. PFEFFER; K. PFIZENMAIER; P. SCHEURICH, CYTOKINE & GROWTH FACTOR REVIEWS, (1998), vol. 9, page 297
    - A. ASHKENAZI; V. M. DIXIT, SCIENCE, (1998), vol. 281, page 1305
    - G. G. KLAUS ET AL., INT. REV. IMMUNOL., (1997), page 15
    - R. HORIE; T. WATANABE, SEMIN. IMMUNOL., (1998), vol. 10, page 457
    - M. LENARDO ET AL., ANNU. REV. IMMUNOL., (1999), vol. 17, page 221
    - D. WALLACH ET AL., ANNU. REV. IMMUNOL., (1999), vol. 17, page 331
    - A. M. CHINNAIYAN; K. O'ROUKE; M. TEWARI ET AL., CELL, (1995), vol. 81, page 505
    - M. P. BOLDIN ET AL., J. BIOL. CHEM., (1995), vol. 270, page 7795
    - M. MUZIO ET AL., CELL, (1996), vol. 85, page 817
    - M. P. BOLDIN; T. M. GONCHAROV; Y. V. GOLTSEV ET AL., CELL, (1996), vol. 85, page 805
    - H. HSU; J. HUANG; H. SHU ET AL., IMMUNITY, (1996), vol. 4, page 387
    - H. SHU; M. TAKEUCHI; D. V. GOEDDEL, PROC. NATL. ACAD. SCI. U.S.A., (1996), vol. 93, page 13973
    - A. T. TING; F. X. PIMENTEL-MUINOS; B. SEED, EMBO J., (1996), vol. 15, page 6189
    - Y. JIANG; J. D. WORONICZ; W. LIU ET AL., SCIENCE, (1999), vol. 283, page 543
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.